Jiangsu Hengrui Pharmaceuticals Co.,Ltd (SHA:600276)
China · Delayed Price · Currency is CNY 52.93
+4.26 (8.75%)
Jun 29, 2026, 3:00 PM CST
SHA:600276 Stock Forecast
Stock Price Forecast
According to 20 analysts polled by S&P Global, SHA:600276 stock has a consensus rating of "Strong Buy" and an average price target of ¥81.14. The average 1-year stock price forecast is 53.30% higher than the current stock price, while the lowest is ¥68.00 (+28.47%) and the highest is ¥123.00 (+132.38%).
Price Target: ¥81.14 (+53.30%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for SHA:600276 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 16 | 16 | 17 | 16 | 16 | 15 |
| Buy | 5 | 5 | 4 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 23 | 23 | 22 | 21 | 21 | 20 |
Financial Forecast
Revenue This Year
35.76B
from 31.63B
Increased by 13.07%
Revenue Next Year
41.06B
from 35.76B
Increased by 14.81%
EPS This Year
1.47
from 1.14
Increased by 29.37%
EPS Next Year
1.73
from 1.47
Increased by 17.04%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 37.1B | ||
| Avg | 35.8B | ||
| Low | 35.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 17.2% | ||
| Avg | 13.1% | ||
| Low | 11.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.60 | ||
| Avg | 1.47 | ||
| Low | 1.31 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 40.4% | ||
| Avg | 29.4% | ||
| Low | 15.1% |